Common use of No Unauthorized Disclosure of Confidential Information Clause in Contracts

No Unauthorized Disclosure of Confidential Information. Beginning on the Effective Date and continuing throughout the term of this Agreement and thereafter for a period of three (3) years, receiving Party shall not disclose or otherwise make known or available to any Third Party any disclosing Party Confidential Information, without the express prior written consent of disclosing Party. Notwithstanding the foregoing, receiving Party shall be permitted to disclose disclosing Party Confidential Information to (i) actual or potential investors, lenders, THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. consultants, collaborators, Sublicensees, or development partners, which disclosure will be made under conditions of confidentiality and limited use; and (ii) its attorney or agent as reasonably required. University shall be permitted to disclose Company Confidential Information to FHCRC; provided, however that such disclosure will be made under conditions of confidentiality and limited use and any such disclosed Company Confidential Information will be deemed and treated as Confidential Information of University under the Inter-Institutional Agreement. In no event shall receiving Party incorporate or otherwise use disclosing Party’s Confidential Information in connection with any patent application filed by or on behalf of receiving Party. Receiving Party shall restrict the use of disclosing Party’s Confidential Information exclusively to the terms of this Agreement. Receiving Party shall use reasonable procedures to safeguard disclosing Party’s Confidential Information. In the case where Company is the receiving Party, Company acknowledges and agrees that its confidentiality obligations also apply equally to its Sublicensees.

No Unauthorized Disclosure of Confidential Information. Beginning on the Effective Date and continuing throughout the term of this Agreement and thereafter for a period of three five (35) yearsyears ("Confidentiality Period"), receiving neither Party shall not use for any purpose or disclose or otherwise make known or available to any Third Party any disclosing Party Confidential InformationInformation disclosed to it by the other Party, without the express prior written consent of disclosing such other Party. Each Party shall utilize reasonable procedures to safeguard the Confidential Information disclosed to it by the other Party. Notwithstanding the foregoingabove, receiving Party Company shall be permitted to (i) disclose disclosing Party University Confidential Information to (i) actual or potential investors, lenders, THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. consultants, collaborators, Sublicensees, or development partners, attorneys or advisors, which disclosure will shall be made under conditions of confidentiality and limited use; and (ii) its attorney or agent so far as reasonably required. University shall be permitted to disclose Company Confidential Information to FHCRC; provided, however that such disclosure will be made practicable under conditions of confidentiality and limited use and provided Company is liable to University for any such disclosed Company breaches of confidentiality relating to University Confidential Information will be deemed resulting from such disclosure; and treated as (ii) disclose Confidential Information of University (A) to the extent necessary to fulfill its obligations and/or duties hereunder which disclosure shall be made so far as reasonably practicable under conditions of confidentiality and limited use (B) in filing for, prosecuting or maintaining any proprietary rights, and (C) in its regulatory filings or other communications with the Inter-Institutional AgreementUS Food and Drug Administration or equivalent foreign regulatory authority pertaining to Licensed Products. In no event shall receiving Party incorporate or otherwise Company will immediately inform University, and provide University with a copy of any use disclosing Party’s of University Confidential Information in a form that could result in public disclosure, including use in any patent application filings. Notwithstanding the foregoing, Company or Sublicensees may not disclose Confidential Information of University that comprises data, a summary of the results of any data, or conclusions from any data, in any patent application or in connection with any patent application filed by filing, prosecution, or on behalf maintenance of receiving Party. Receiving Party shall restrict any proprietary rights without the use express written permission of disclosing Party’s Confidential Information exclusively the University, such permission not to the terms of this Agreement. Receiving Party shall use reasonable procedures to safeguard disclosing Party’s Confidential Information. In the case where Company is the receiving Party, Company acknowledges and agrees that its confidentiality obligations also apply equally to its Sublicenseesbe unreasonably withheld.